Markus Enzelberger
Private Equity Investor at Versant Venture Management LLC
Network origin in Markus Enzelberger first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
46
| Public Company | Biotechnology | 46 |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver.
35
| Holding Company | Investment Managers | 35 |
SHS Gesellschaft für Beteiligungsmanagement mbH
 SHS Gesellschaft für Beteiligungsmanagement mbH Investment ManagersFinance SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) is an independent private equity and venture capital firm founded by Bernhard Schirmers and Reinhilde Spatscheck in 1993, and was headquartered in Tübingen, Baden-Württemberg in the southwest of Germany.
16
| Private Company | Investment Managers | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Markus Enzelberger via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| QIAGEN N.V. | Medical Specialties | Founder Public Communications Contact | |
| BAYER AG | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| 4SC AG | Biotechnology | Investor Relations Contact Director/Board Member | |
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member | |
| AFFIMED N.V. | Biotechnology | Chief Tech/Sci/R&D Officer Public Communications Contact | |
| NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Chairman Chief Tech/Sci/R&D Officer Private Equity Investor | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| MEDIGENE AG | Biotechnology | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
| Golden Gate University | College/University | Graduate Degree Graduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Doctorate Degree Doctorate Degree | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Public Communications Contact Human Resources Officer General Counsel | |
| Georgetown University | College/University | Masters Business Admin Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| University of Münster | College/University | Undergraduate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal Private Equity Investor | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Chairman | |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal Graduate Degree | |
Inception Sciences, Inc.
 Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Inception Sciences, Inc. provides small molecule pharmaceutical incubator services. Its focus is on creating therapies with transformative potential to address diseases and disorders. The company creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded in 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| CRISPR THERAPEUTICS AG | Biotechnology | Chairman Director/Board Member Chief Operating Officer | |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member Founder Corporate Officer/Principal | |
Inception IBD, Inc.
 Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Inception IBD, Inc. provides therapeutics services. It creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded by Eric Ogier-Denis, Yoram Bouhnik, Xavier Treton and Jacques Mizrahi in 2011 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
Versant Venture Capital VI (Canada) LP
 Versant Venture Capital VI (Canada) LP Investment ManagersFinance Versant Venture Capital VI (Canada) LP operates as a pooled investment fund. The company is headquartered in San Francisco, CA. | Investment Managers | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
858 Therapeutics, Inc.
 858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
CODA Biotherapeutics, Inc.
 CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA. | Medical Specialties | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Jengu Therapeutics, Inc.
 Jengu Therapeutics, Inc. BiotechnologyHealth Technology Jengu Therapeutics, Inc. is a biotechnology company. The company is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
Monte Rosa Therapeutics AG
 Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
| MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer Chairman | |
Kyras Therapeutics, Inc.
 Kyras Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kyras Therapeutics, Inc. operates as a biopharmaceutical company that develops drugs for incurable cancers and developmental disorders caused by RAS gene mutations. The company was founded by Brent R. Stockwell in 2015 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
Jecure Therapeutics, Inc.
 Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Ventus Therapeutics, Inc.
 Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ventus Therapeutics, Inc. operates as a biopharmaceutical company. It focuses in developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. The company was founded by Hao Wu, Richard Flavell, Judy Lieberman, Thomas Tuschl, and Feng Shao and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| CONTINEUM THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Santa Ana Bio, Inc.
 Santa Ana Bio, Inc. BiotechnologyHealth Technology Santa Ana Bio, Inc. is a biotechnology company that specializes in precision immunology for autoimmune diseases. The company is based in Alameda, CA. The CEO of the company is Peter Emtage. | Biotechnology | Chief Executive Officer Director/Board Member |
Statistics
International
| United States | 30 |
| Germany | 12 |
| Switzerland | 9 |
| Netherlands | 2 |
| Canada | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Finance | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 324 |
| Corporate Officer/Principal | 176 |
| Chairman | 91 |
| Independent Dir/Board Member | 78 |
| Chief Executive Officer | 61 |
Most connected contacts
| Insiders | |
|---|---|
| Bradley Bolzon | 41 |
| Thomas Woiwode | 39 |
| George Golumbeski | 36 |
| Daniel Camus | 31 |
| Gerald Heinz Möller | 29 |
| Karin Eastham | 29 |
| Kirk Nielsen | 25 |
| Wendy Johnson | 23 |
| David Lemus | 22 |
| Jeremy S. Caldwell | 22 |
| Carlo Rizzuto | 22 |
| Frank Morich | 21 |
| Paul Grayson | 21 |
| Hans Jörg Reinhardt | 20 |
| Alexander Mayweg | 18 |
- Stock Market
- Insiders
- Markus Enzelberger
- Company connections
